baber/WOPTO huggingface dataset:
Patent JP-H0768531-B2 (JP)
IPC: C10L9/02
Filed: 1987-03-23
Abstract: PCT No. PCT/AU87/00080 Sec. 371 Date Sep. 19, 1988 Sec. 102(e) Date Sep. 19, 1988 PCT Filed Mar. 23, 1987 PCT Pub. No. WO87/05621 PCT Pub. Date Sep. 24, 1987.The invention concerns a process for the preparation of demineralized coal, comprising the steps of: (a) forming a slurry of coal particles, preferably at least 50% by weight of which particles have a maximum dimension of at least 0.5 mm, with an aqueous solution of an alkali, which solution has an alkali content of from 5 to 30% by weight, such that the slurry has an alkali solution to coal ratio on a weight basis of at least 1:1; (b) maintaining the slurry at a temperature of from 150 DEG  to 300 DEG C., preferably 170 DEG  C. to 230 DEG  C., for a period of from 2 to 20 minutes substantially under autogenous hydrothermal pressure and rapidly cooling the slurry to a temperature of less than 100 DEG  C.; (c) separating the slurry into alkalized coal and a spent alkali leachant solution; (d) regenerating the alkali leachant solution for reuse in step (a) above by the addition of calcium or magnesium oxide or hydroxide thereto to precipitate minerals therefrom; (e) acidifying the alkalized coal by treatment with an aqueous solution of sulphuric or sulphurous acid to yield a slurry having a pH of from 0.5 to 1.5 and a conductivity of from 10,000 to 100,000  mu s; (f) separating the slurry into acidified coal and a spent acid leachant solution; and (g) washing the acidified coal.
Patent JP-3828570-B2 (JP)
IPC: C12N15/12
Filed: 1992-07-20
Granted: 2006-10-04
Abstract: Method of prodn. of papilloma virus (PV) like particles (VLPs) comprises: (a) constructing one or more recombinat DNA molecules which each encode papilloma virus L1 protein or a combination of papilloma virus L1 protein and papilloma virus L2 protein and (b) transfecting a suitable host cell with the one or more recombinant DNA molecules so that VLPs are produced within the cell after expression of the L1 or combination of L1 and l2 proteins. Also claimed are ; (a) VLPs derived from papilloma virus contg. proteins L1 and L2; (b) VLPs derived from HPV16 contg. proteins L1 and L2; (c) VLPs derived from BPV1 contrg. proteins L1 and L2 (d) VLPs derived from BPV1 contg. protein L1; (e) VLPs derived from HPV11 contg. protein L1; (f) VPs derived from HPV6b contg. proteins L1 and L2; (g) VLPs derived from HPV6b contg. protein L1; (h) plasmid pLC201; (i) viruses doubly recombinant for PV capsid proteins L1 and L2; (j) viruses recombinant for PV capsid protein L1; (k) plasmid pLC200; (l) 5'-CAGATCTATGTCTCTTT -GGCTGCCTAGTGAGGCC-3'; (m) 5'-CAGATCTAATCAGCTTA -CGTTTTTTGCGTTTAGC-3'; (n) pLC 201 VV; etc.
Patent JP-3183406-B2 (JP)
IPC: C02F/
Filed: 1991-01-22
Granted: 2001-07-09
Abstract: A method for water purification in which waste water is fed into a reactor containing carriers having a biofilm which promotes a desired conversion of impurities, using carriers which are particulate elements having a larger surface than smooth elements of the same dimension and having a density in the range 0.90 to 1.20, normally 0.92 till 0.98, particularly 0.92 to 9.96 kg/dm3, wherein the carriers with biofilm are kept suspended in the water in a reactor for aerobic, anoxic or anaerobic water purification, comprising inlet and outlet tubes and optionally mixing means, and containing a large number of carriers for biofilm. This reactor is also comprised by the present invention.
Patent JP-4046351-B2 (JP)
IPC: A61K31/7034
Filed: 1996-06-26
Granted: 2008-02-13
Abstract: The present invention provides compounds having structure (II), and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof.
Patent JP-3714678-B2 (JP)
IPC: C08F4/648
Filed: 1995-07-18
Granted: 2005-11-09
Abstract: Catalysts for the polymerization of olefins which comprise the reaction product of (a) a bridged and/or substituted cyclopentadienyl compound of titanium, zirconium, or hafnium; (b) an organometallic aluminum compound of formula Al(CH2-CR4R5R6)wR7yHz, wherein in the (CH2-CR4R5R6) groups, which are the same or different, R4 is an alkyl, alkenyl or arylalkyl group having from 1 to 10 carbon atoms, R5 is an alkyl, alkenyl, aryl, arylalkyl or alkylaryl group having from 3 to 50 carbon atoms and, optionally, R4 and R5 can be fused together to form a ring having from 4-6 carbon atoms, R6 is hydrogen or an alkyl alkenyl or arylalkyl group having from 1 to 10 carbon atoms, the R7 substituents, the same or different, are alkyl, alkenyl, aryl, arylalkyl or alkylaryl radicals having from 1 to 10 carbon atoms and, optionally, can contain Si or Ge atoms, w is 1, 2 or 3, z is 0 or 1, and y=3-w-z; and (c) water. The molar ratio of aluminum to water is from 1:1 to 100:1. The catalysts show an improved activity with respect to known catalysts wherein an aluminum compound different from those of the invention are used.
Patent JP-2841202-B2 (JP)
IPC: B05B1/34
Filed: 1988-07-05
Granted: 1998-12-24
Abstract: PCT No. PCT/EP88/00598 Sec. 371 Date Jan. 5, 1990 Sec. 102(e) Date Jan. 5, 1990 PCT Filed Jul. 5, 1988 PCT Pub. No. WO89/00086 PCT Pub. Date Jan. 12, 1989.In a manually operable discharging apparatus, the discharge nozzle has an at least two-stage atomizer, in which the medium flow, following pre-atomization, is atomized by surge-like acceleration with a whirled, fine compressed air flow, e.g. according to the Laval, effect, so that even finer droplets are obtained. For this purpose to the discharge nozzle, a separate compressed air channel portion upstream of the end opening supplies compressed air from a time immediately before the supply of medium to a time after its supply. The compressed air can be produced in simple manner by a compressed air pump combined constructionally with the medium pump and operable together therewith by means of a single handle and which in the extension of medium pump is provided immediately adjacent to its outer end and whose pump cylinder is formed by the cap-like handle. The compressed air flow can also be passed to other points of the discharging apparatus, e.g. for cleaning the medium outlet channel for discharge nozzle and can be used for control functions for valves, particularly outlet valves.
Patent JP-3583785-B2 (JP)
IPC: C12R1/91
Filed: 1995-07-21
Granted: 2004-11-04
Abstract: A control method for operating aqueous microorganism growth processes is disclosed which can maintain viable growth conditions for many types of microorganisms which have heretofore not been easily reproduced in commercially valuable quantities. The primary control parameters are the degree of turbulence in the aqueous growth medium and the scale of the apparatus relative to the scale of the turbulent eddies in vessels which are partially filled with the aqueous medium directly affect conditions which are required for optimum growth: light exposure, nutrient supply, sedimentation rate, bulk temperature, gas exchange rate and cell integrity. These control elements can be cast in terms of the Reynolds number (NRe) and controlled dimensions of the apparatus (LK) in relationship to the scales of turbulent eddies to define the dissipation  lambda K as LK/L. Alternatively, these can be recognized to show that the delivery of nutrients to the microorganism mass is dependent upon the dissipation rate  epsilon  in the fluid, which allows a definition of Lk to be quantified. The broadest ranges generally useful in this invention are NRe=2000 to 106, preferably 4000 to 250,000; apparatus scale relative to eddy scale is such that the level of fluid in the reaction chamber relative to eddy scale is 10-1:1 preferably 10-1.2:1; and turbulent energy dissipation rate  epsilon  between 10-3 and 10 W/kg. The invention is particularly useful in controlling growth processes in which the microorganisms are unicellular algae, phytoplankton, issues of vascular plants, tissues of macroalgae, and the like.
Patent JP-4255512-B2 (JP)
IPC: A61K47/48
Filed: 1995-08-01
Granted: 2009-04-15
Abstract: Polyspecific immunoconjugates and antibody composites that bind a multidrug transporter protein and an antigen associated with a tumor or infectious agent are used to overcome the multidrug resistant phenotype. These immunoconjugates and composites also can be used diagnostically to determine whether the failure of traditional chemotherapy is due to the presence of multidrug resistant tumor cells, multidrug resistant HIV-infected cells or multidrug resistant infectious agents.
Patent JP-2539326-B2 (JP)
IPC: H01R4/24
Filed: 1992-02-21
Granted: 1996-10-02
Abstract: A telecommunications terminal block employs a housing having a number of separate dielectrically, isolated chambers disposed therein. Service wires to be connected to a splice cable are inserted into a chamber through openings in the housing and into a movable wire carrier member disposed within the chamber. An actuator member drives the carrier member from a first position, at which the wires are inserted, to a second position where the wires engage a contact element which electrically couples them to the splice cable. The carrier member moves within the chamber so as to allow, an electrically insulating medium within the chamber to flow around the carrier and maintain a constant volume of the medium within the chamber. Loss of insulating medium is thereby avoided during connection and reconnection of the service wires allowing improved protection from environmental factors such as moisture, chemicals and other contaminants.
Patent JP-3382949-B2 (JP)
IPC: B29K7/00
Filed: 1996-08-23
Granted: 2003-03-04
Abstract: A method for the production of a natural rubber latex emulsion having normal physical, mechanical, and chemical properties and having reduced allergenicity, said method comprising the steps of:   providing a natural rubber latex emulsion including naturally occurring antigenic surfactant-type molecules; and chemically treating said latex emulsion with a screening agent to crosslink and induce blooming of the antigenic surfactant-type molecules at the emulsion interfaces.
Patent JP-3377524-B2 (JP)
IPC: A61K38/30
Filed: 1991-05-30
Granted: 2003-02-17
Abstract: Healing an external wound and/or regenerating bone of a mammal by administering to the mammal a composition containing purified transforming growth factor beta and purified Insulin-like growth factor-I or purified Insulin-like growth factor-II.
Patent JP-2838234-B2 (JP)
IPC: B23G3/00
Filed: 1993-01-21
Granted: 1998-12-16
Abstract: An in-die tapping tool having particular application to a progressive die method for threading holes in a sheet metal workpiece. The tapping includes a transmission system comprising a threaded shaft assembly and a planetary roller nut. The roller nut is adapted to move axially along the shaft assembly in response to an impact force applied to the tapping tool during the downstroke of the press. The movement of the roller nut causes the shaft assembly to rotate, which rotation is imparted to a threaded lead screw to cause the lead screw to simultaneously rotate and ride axially along a threaded wall of a hollow cylindrical body. The rotational and axial movements of the lead screw through the cylindrical body are transferred to the tap to correspondingly induce a rotation and advancement of the tap towards the workpiece having the holes to be threaded. However, the axial location of the rotatable shaft assembly relative to the workpiece remains unchanged.
Patent JP-3317500-B2 (JP)
IPC: A61F2/82
Filed: 1995-10-17
Granted: 2002-08-26
Abstract: The methods and apparatus of the present invention permit stable transcutaneous access. Some preferred embodiments of the invention provide body pocket access channels that provide stable means for communicating between the exterior of the body and a natural or created internal body pocket. Other embodiments involve the inclusion of an attachment element surrounding a device sought to be passed from a location external of a patient's body to a location within the body at the exit site, but which are attached to the device at a location within the body rather than at the exact location where the device passes through a patient's skin, thereby forming a body pocket that will reduce stress or strain at the exit site. Several alternative embodiments for effecting body pockets through use of attachment elements are disclosed.
Patent JP-3022990-B2 (JP)
IPC: G11C29/44
Filed: 1991-08-29
Granted: 2000-03-21
Abstract: PCT No. PCT/DE91/00685 Sec. 371 Date Mar. 5, 1993 Sec. 102(e) Date Mar. 5, 1993 PCT Filed Aug. 29, 1991 PCT Pub. No. WO92/04717 PCT Pub. Date Mar. 19, 1992.A circuit arrangement for testing a semiconductor memory, in which various test bit patterns can be written into a register (REG) and into memory cell n-tuples (NSPZ), in which the test bit pattern in the register (REG) can be compared with the bit patterns in the memory cell n-tuples (NSPZ) by a multiplicity of comparator circuits (MC), in which the comparator outputs (Mik) are combined by pairs of wired-OR lines to an address matrix (AM), to enable fault location, and in which individual faults (PTSF) and/or multiple faults (PTMF) can be identified by means of a fault type identification circuit (FTE).
Patent JP-4223557-B2 (JP)
IPC: C07D498/06
Filed: 1997-09-26
Granted: 2009-02-12
Abstract: This invention provides a derivative, and an excellent pharmaceutical preparation, which has strong antibacterial activity against Gram-negative and Gram-positive bacteria and shows both excellent pharmacokinetics and high safety. Particularly, it provides a pyridobenzoxazine derivative represented by formula (I): <CHEM>  wherein   R<1>: a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, in which said alkyl group may have a substituent selected from the group consisting of a hydroxyl group, a halogen atom, an alkylthio group having 1 to 6 carbon atoms and an alkoxyl group having 1 to 6 carbon atoms; R<2>: a hydrogen atom or an amino group, in which said amino group may have one or two substituents selected from the group consisting of a formyl group, an alkyl group having 1 to 6 carbon atoms and an acyl group having 2 to 6 carbon atoms; R<3>: a hydrogen atom, a phenyl group, an acetoxymethyl group, a pivaloyloxymethyl group, an ethoxycarbonyl group, a choline group, a dimethylaminoethyl group, a 5-indanyl group, a phthalidinyl group, a 5-alkyl-2-oxo-1,3-dioxol-4-ylmethyl, a 3-acetoxy-2-oxobutyl group, an alkyl group having 1 to 6 carbon atoms, an alkoxymethyl group having 2 to 7 carbon atoms, a phenylalkyl group composed of an alkylene group having 1 to 6 carbon atoms and a phenyl group; and a salt thereof or a hydrate thereof, or an antibacterial agent containing the same as its active ingredient.
Patent JP-3153238-B2 (JP)
IPC: C08K3/00
Filed: 1991-06-24
Granted: 2001-04-03
Abstract: A monomer-rich acrylic syrup is cast including about 10% to about 20% ground acrylic particles. During curing, the particles absorb over half their weight in monomer, and a cured sheet is formed in which the matrix monomer and uncrosslinked polymer form a phase which extends through the particles, while the particles appear to be fused together. Including a crosslinker in the syrup further insures the interpenetration of the matrix phase into the swollen particles. A textured surface is formed, which is useful as an anti-slip surface in bathtubs and shower stalls, after thermoforming.
Patent JP-4195728-B2 (JP)
IPC: A61P31/04
Filed: 1997-10-14
Granted: 2008-12-10
Abstract: Pharmaceutical compositions containing a proanthocyanidin polymer composition which are useful for the treatment and prevention of secretory diarrhea are provided. The invention specifically relates to pharmaceutical formulations of a proanthocyanidin polymer composition which has been isolated from a Croton spp. or a Calophyllum spp. In particular, the invention relates to a formulation of a proanthocyanidin polymer composition which protects the composition from the effects of stomach acid after oral administration, particularly to those formulations which are enteric coated. Methods for use of the formulations as well as methods for use of the proanthocyanidin polymer composition in combination with an effective amount of a compound effective either to inhibit secretion of stomach acid or to neutralize stomach acid are disclosed.
Patent JP-3593132-B2 (JP)
IPC: C12R1/37
Filed: 1995-11-27
Granted: 2004-11-24
Abstract: PCT No. PCT/SE95/01416 Sec. 371 Date Dec. 18, 1995 Sec. 102(e) Date Dec. 18, 1995 PCT Filed Nov. 27, 1995A compound of formula (II), either as a single enantiomer or in an enantiomerically enriched form    <IMAGE>  (II)  wherein:   <IMAGE>   and   <IMAGE>    <IMAGE>   (wherein N in the benzimidazole moiety of Het2 means that one of the carbon atoms substituted by any one of R6 to R9 optionally may be exchanged for an unsubstituted nitrogen atom; R1, R2 and R3 are the same or different and selected from hydrogen, alkyl, alkoxy optionally substituted by fluorine, alkylthio, alkoxyalkoxy, dialkylamino, piperidino, morpholino, halogen, phenylalkyl, phenylakoxy; R4 and R4, are the same or different and selected from hydrogen, alkyl, aralkyl; R5 is hydrogen, halogen, trifluoromethyl, alkyl, alkoxy; R6 -R9 are the same or different and selected from hydrogen, alkyl, alkoxy, halogen, haloalkoxy, alkylcarbonyl, alkoxycarbonyl, oxazolyl, trifluoroalkyl or adjacent groups R6 -R9 may complete together with the carbon atoms to which they are attached optionally substituted ring structures; R10 is hydrogen or alkoxycarbonyloxymethyl; R11 is hydrogen or forms an alkylene chain together with R3; R12 and R13 are the same or different and selected from hydrogen, halogen or alkyl) is obtained by stereoselective bioreduction of a compound of formula (II) in racemic form.
Patent JP-3456484-B2 (JP)
IPC: H04M3/22
Filed: 1995-01-19
Granted: 2003-10-14
Abstract: A method and an apparatus for off-hook detection in a subscriber line interface circuit responds to a ringing signal which preferably lacks a DC component. A signal is generated that is a function of the line current through the subscriber line, and the time at which the signal exceeds a predetermined current value is measured. The measured time is compared with a predetermined time value, and an off-hook indication is produced in a processor depending on the comparison.
Patent JP-3523261-B2 (JP)
IPC: C07K1/26
Filed: 1995-01-23
Granted: 2004-04-26
Abstract: A Capillary Electrophoresis apparatus and method are disclosed which utilize a meltable plug in an end of the capillary tube to selectively pass small ionic contaminants electrophoretically and retain macromolecular analytes against one end of the plug until the plug is melted. When this plug is melted, the analytes and the contaminants pass through unimpeded. This permits separation of the analytes from the contaminants during electrophoretic separation and enhances instrument resolution.
Patent JP-3534766-B2 (JP)
IPC: B65D59/02
Filed: 1995-02-09
Granted: 2004-06-07
Abstract: PCT No. PCT/SE95/00133 Sec. 371 Date Aug. 8, 1996 Sec. 102(e) Date Aug. 8, 1996 PCT Filed Feb. 9, 1995 PCT Pub. No. WO95/21777 PCT Pub. Date Aug. 17, 1995The invention relates to a method and an arrangement for closing of at least one end of a tube to protect the tube (8) against internal dirtying. According to the method, a strip (5) comprising a number of plugs (4) is fed up to a position in front of a tube (8) situated in a punch sleeve (9), at said position a plug (4) in the strip (5) is in a position just in front of the tube end (12), whereupon a punch (7) presses the strip (5) with the plug (4) against the tube (8) and the punch sleeve (9), so that the punch (7) in the end of its working stroke after pressing the plug (4) into the tube end (12) is punching out the plug (4) from said strip (5). The plug (4) formed for closing of a tube end is together with plugs, formed in the same way, integrally formed one after another at a predetermined distance in a longitudinal row in a continuous strip (5).
Patent JP-4310395-B2 (JP)
IPC: C04B7/147
Filed: 1996-01-24
Granted: 2009-08-05
Abstract: In a method of effectively utilizing dusts incurring in the reduction of iron ore by means of a reducing gas and separated on that occasion in a scrubber in the form of sludges, the sludges at first are dehydrated and are used as starting materials for the production of cement (FIG. 1).
Patent JP-2701990-B2 (JP)
IPC: C10J3/46
Filed: 1995-03-30
Granted: 1998-01-21
Abstract: A method and apparatus are provided for operating a pressurized reactor system in order to precisely control the temperature within a pressure vessel in order to minimize condensation of corrosive materials from gases on the surfaces of the pressure vessel or contained circulating fluidized bed reactor, and to prevent the temperature of the components from reaching a detrimentally high level, while at the same time allowing quick heating of the pressure vessel interior volume during start-up. Superatmospheric pressure gas is introduced from the first conduit into the fluidized bed reactor and heat derived reactions such as combustion and gassification are maintained in the reactor. Gas is exhausted from the reactor and pressure vessel through a second conduit. Gas is circulated from one part of the inside volume to another to control the temperature of the inside volume, such as by passing the gas through an exterior conduit which has a heat exchanger, control valve, blower and compressor associated therewith, or by causing natural convection flow of circulating gas within one or more generally vertically extending gas passages entirely within the pressure vessel (and containing heat exchangers, flow rate control valves, or the like therein). Preferably, inert gas is provided as a circulating gas, and the inert gas may also be used in emergency shut-down situations. In emergency shut-down reaction gas being supplied to the reactor is cut off, while inert gas from the interior gas volume of the pressure vessel is introduced into the reactor.
Patent JP-3662028-B2 (JP)
IPC: A61K31/435
Filed: 1997-02-17
Granted: 2005-06-22
Abstract: PCT No. PCT/FR97/00296 Sec. 371 Date Aug. 12, 1998 Sec. 102(e) Date Aug. 12, 1998 PCT Filed Feb. 17, 1997 PCT Pub. No. WO97/29753 PCT Pub. Date Aug. 21, 1997The invention relates to a pharmaceutical composition containing an association of active principles, wherein the active principles are clopidogrel and aspirin, each constituent being present in a free form or in the form of a pharmaceutically acceptable salt.
Patent JP-3962432-B2 (JP)
IPC: C08F4/80
Filed: 1997-03-06
Granted: 2007-08-22
Abstract: The present invention relates to a radiation sensitive photoresist composition comprising a photoacid initiator and a polycyclic polymer comprising repeating units that contain pendant acid labile groups. Upon exposure to an imaging radiation source the photoacid initiator generates an acid which cleaves the pendant acid labile groups effecting a polarity change in the polymer. The polymer is rendered soluble in an aqueous base in the areas exposed to the imaging source.
Patent JP-4026861-B2 (JP)
IPC: A23L3/00
Filed: 1999-03-30
Granted: 2007-12-26
Abstract: A device for introducing containers into a treatment space and for removing the containers from said treatment space having at least one rotatable sluice wheel provided on the periphery with sluice chambers that are open toward the outside, the sluice wheel being provided with grippers that can be operated directly by the containers or indirectly by a control device, for securing the containers temporarily in the sluice chambers, preferably by suspending the containers without allowing them to come in contact with the chamber walls and without providing any bottom support. A trouble-free conveyance of the containers with a very high output is possible without damaging the containers, even when the containers are very susceptible to tilting.